- Current report filing (8-K)
July 13 2010 - 3:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): July 6, 2010
Impax Laboratories,
Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Delaware
|
|
001-34263
|
|
65-0403311
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
30831 Huntwood Avenue,
Hayward, CA
|
|
94544
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
(510) 476-2000
|
Not
Applicable
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 8.01 Other Events.
On July 6, 2010,
Impax Laboratories, Inc. and Wells Fargo Bank, National Association (successor
by merger to Wachovia Bank, National Association) entered into, effective as of
June 30, 2010, a Fifth Amendment to Amended and Restated Loan and Security
Agreement, dated as of December 15, 2005, as amended, which extended the
termination date of the agreement from June 30, 2010 to September 30,
2010.
1
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
Dated: July 13, 2010
|
IMPAX LABORATORIES, INC.
|
|
|
By:
|
/s/ Arthur A. Koch, Jr.
|
|
|
|
Name:
|
Arthur A. Koch, Jr.
|
|
|
|
Title:
|
Senior Vice President, Finance, and
Chief Financial Officer
|
|
|
2
3
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From May 2024 to Jun 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jun 2023 to Jun 2024